Loratadine - Revision history

Rossdonaldson1: /* Lactation risk */

2026-05-20T21:35:20Z

Lactation risk

← Older revision		Revision as of 21:35, 20 May 2026
Line 34:		Line 34:

	===Lactation risk===		===Lactation risk===
	*		*Caution is advised; nursing mothers may use the medication for a short time. Both loratadine and its active metabolite pass readily into breast milk. There is no known risk of infant harm based on the drug's properties and the currently limited human data.

	===Renal Dosing===		===Renal Dosing===

Rossdonaldson1: /* Pregnancy Rating */

2026-05-20T21:34:58Z

Pregnancy Rating

← Older revision		Revision as of 21:34, 20 May 2026
Line 31:		Line 31:
	==Special Populations==		==Special Populations==
	===[[Drug pregnancy categories\|Pregnancy Rating]]===		===[[Drug pregnancy categories\|Pregnancy Rating]]===
	*		*Should be safe for use during pregnancy; the risk of harm to the fetus is not expected based on limited human data;

	===Lactation risk===		===Lactation risk===

Rossdonaldson1 at 21:34, 20 May 2026

2026-05-20T21:34:01Z

← Older revision		Revision as of 21:34, 20 May 2026
Line 17:		Line 17:
	==Pediatric Dosing==		==Pediatric Dosing==
	===[[Allergic rhinitis]]===		===[[Allergic rhinitis]]===
	*Children aged ~~6 and older~~		*Children aged ≥6 years old
	**10 mg PO once daily, OR		**10 mg PO once daily, OR
	*Children aged 2 to 5		*Children aged 2 to 5
Line 25:		Line 25:

	===[[Urticaria]]===		===[[Urticaria]]===
	*Children aged ~~6 and older~~		*Children aged ≥6 years old
	**10 mg PO once daily		**10 mg PO once daily
	***Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits.		***Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits.

Rossdonaldson1: /* Allergic rhinitis */

2026-05-20T21:32:51Z

Allergic rhinitis

← Older revision		Revision as of 21:32, 20 May 2026
Line 23:		Line 23:
	**Do not exceed 10 mg in 24 hours		**Do not exceed 10 mg in 24 hours
	**The ODT formulation is not recommended for younger children.		**The ODT formulation is not recommended for younger children.

			===[[Urticaria]]===
			*Children aged 6 and older
			**10 mg PO once daily
			***Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits.

	==Special Populations==		==Special Populations==

Rossdonaldson1: /* Adult Dosing */

2026-05-20T21:31:50Z

Adult Dosing

← Older revision		Revision as of 21:31, 20 May 2026
Line 7:		Line 7:
	==Adult Dosing==		==Adult Dosing==
	===[[Allergic rhinitis]]===		===[[Allergic rhinitis]]===
	*10 mg ~~orally~~ once daily, OR		*10 mg PO once daily, OR
	*5 mg twice daily		*5 mg twice daily
	*Do not exceed 10 mg in 24 hours		*Do not exceed 10 mg in 24 hours

			===[[Urticaria]]===
			*10 mg PO once daily
			**Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits.

	==Pediatric Dosing==		==Pediatric Dosing==

Rossdonaldson1 at 21:27, 20 May 2026

2026-05-20T21:27:49Z

← Older revision		Revision as of 21:27, 20 May 2026
Line 12:		Line 12:

	==Pediatric Dosing==		==Pediatric Dosing==
			===[[Allergic rhinitis]]===
	*Children aged 6 and older		*Children aged 6 and older
	**10 mg PO once daily, OR		**10 mg PO once daily, OR

Rossdonaldson1: /* Pediatric Dosing */

2026-05-20T21:27:34Z

Pediatric Dosing

← Older revision		Revision as of 21:27, 20 May 2026
Line 12:		Line 12:

	==Pediatric Dosing==		==Pediatric Dosing==
			*Children aged 6 and older
			**10 mg PO once daily, OR
			*Children aged 2 to 5
			**5 mg PO once daily
			**Do not exceed 10 mg in 24 hours
			**The ODT formulation is not recommended for younger children.

	==Special Populations==		==Special Populations==

Rossdonaldson1: /* Adult Dosing */

2026-05-20T21:25:46Z

Adult Dosing

← Older revision		Revision as of 21:25, 20 May 2026
Line 6:		Line 6:

	==Adult Dosing==		==Adult Dosing==
			===[[Allergic rhinitis]]===
			*10 mg orally once daily, OR
			*5 mg twice daily
			*Do not exceed 10 mg in 24 hours

	==Pediatric Dosing==		==Pediatric Dosing==

Rossdonaldson1: /* Administration */

2026-05-20T21:19:47Z

Administration

← Older revision		Revision as of 21:19, 20 May 2026
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: [[H1 antagonists]] (second generation)		*Type: [[H1 antagonists]] (second generation)
	*Dosage Forms:		*Dosage Forms: Tablets (chewable or orally disintegrating tablets [ODTs]), liquid-filled capsules, or a syrup (1 mg/mL solution)
	*Routes of Administration: Oral		*Routes of Administration: Oral
	*Common Trade Names:		*Common Trade Names: Claritin

	==Adult Dosing==		==Adult Dosing==

Rossdonaldson1: Created page with "==Administration== Type: H1 antagonists (second generation) Dosage Forms: Routes of Administration: Oral Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== ===Pregnancy Rating=== * ===Lactation risk=== * ===Renal Dosing=== Adult: Pediatric: ===Hepatic Dosing=== Adult: Pediatric: ==Contraindications== *Allergy to class/drug ==Adverse Reactions== ===Serious=== ===Common=== ==Pharmacolo..."

2026-05-20T21:18:09Z

Created page with "==Administration== *Type: H1 antagonists (second generation) *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== ===Pregnancy Rating=== * ===Lactation risk=== * ===Renal Dosing=== *Adult: *Pediatric: ===Hepatic Dosing=== *Adult: *Pediatric: ==Contraindications== *Allergy to class/drug ==Adverse Reactions== ===Serious=== ===Common=== ==Pharmacolo..."

New page

==Administration==
*Type: [[H1 antagonists]] (second generation)
*Dosage Forms:
*Routes of Administration: Oral
*Common Trade Names:

==Adult Dosing==

==Pediatric Dosing==

==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*

===Lactation risk===
*

===Renal Dosing===
*Adult:
*Pediatric:

===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===

===Common===

==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:

==Mechanism of Action==

==Comments==

==See Also==

==References==
<references/>

[[Category:Pharmacology]]